Copyright: ©Author(s) 2026.
World J Diabetes. Jun 15, 2026; 17(6): 118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Figure 12 Tangwang formula improved jejunum and ileum histopathology in diabetic retinopathy mice (n = 6, 40 ×).
A: Hematoxylin and eosin staining of the jejunum, and statistical analysis of villus height, crypt depth, and villus height/crypt depth ratio; B: Hematoxylin and eosin staining of the ileum, and statistical analysis of villus height, crypt depth, and villus height/crypt depth ratio; C: Periodic acid-Schiff staining of the jejunum, and the number of goblet cell; D: Periodic acid-Schiff staining of the ileum, and the number of goblet cell. The data are expressed as mean ± SD, bP < 0.01 vs control group, and dP < 0.01 vs model group. CaD: Calcium dobesilate; TWF: Tangwang formula.
- Citation: Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; 17(6): 118650
- URL: https://www.wjgnet.com/1948-9358/full/v17/i6/118650.htm
- DOI: https://dx.doi.org/10.4239/wjd.118650